Digital Storytelling Intervention for Cancer Patients Undergoing Hematopoietic Cell Transplantation
Overview
Tab Title Description
Study type
InterventionalDescribes the nature of a clinical study. Types include:
- Observational study — observes people and measures outcomes without affecting results.
- Interventional study (clinical trial) — studies new tests, treatments, drugs, surgical procedures or devices.
- Medical records research — uses historical information collected from medical records of large groups of people to study how diseases progress and which treatments and surgeries work best.
Study IDs
Site IRB
- Scottsdale/Phoenix, Arizona: 14-009823
NCT ID: NCT03654599
Sponsor Protocol Number: GR11968
About this study
The study is testing the effectiveness of digital story intervention in caregivers of patients who have recently undergone transplant for hematopoietic cell malignancies. Research has shown that viewing presentation of HCT stories from individuals who have similar experiences with their diagnosis and treatment and have a wide range of emotional expression or resolutions have beneficial effects on emotional wellbeing. We will use the information from this study to help us to evaluate the use of this intervention to minimize emotional distress among HCT caregivers.
Participation eligibility
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.
Inclusion Criteria:
- Phase 1
- Adult HCT survivors (18 years or older) who have completed transplant within the past 2 years, any gender, race or ethnicity. Able to speak, read, and write English.
- Phase 2
- Adult patients (18 years or older) undergoing HCT for a hematological malignancy, any gender, race or ethnicity. Able to speak, read, and write English.
Exclusion Criteria:
- Cognitive impairment that would prevent them from fully participating.
Participating Mayo Clinic locations
Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.
| Mayo Clinic Location |
Status |
|
Scottsdale/Phoenix, Ariz.
Mayo Clinic principal investigator Nandita Khera, M.D., M.P.H. |
Closed for enrollment |
|
More information
Publications
Publications are currently not available